Main Session
Sep
28
PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2790 - Risk-Adapted Consolidative Radiotherapy in Rituximab-Treated Diffuse Large B-Cell Lymphoma: A Single-Institution Cohort
Presenter(s)
Tao Liu, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan,